PADI4 and cancer: The use of PAD inhibitors has already been investigated in animal models to treat cancer or atherosclerotic lesions (Knight et al, 2014; Li et al, 2020) and would represent one potential way of eliminating NETs and hence naRNA-mediated inflammation.